Latest News from EMD

There are a few well-known mitigation measures you can follow to keep yourself and your loved ones safe during the holidays. YSPH Dr. Albert Ko provides some guidance.

Roughly $10 million in federal aid will flow to the New Haven area over the next five years to help municipal health departments take a regional approach in combating the opioid epidemic. YSPH Professor Robert Heimer is helping to lead the effort.

Thousands of Ukrainian children have reportedly been taken from their homes and moved to camps in Russia or Belarus since the start of the war. Nathaniel Raymond, director of the Yale Humanitarian Research Lab at the Yale School of Public Health, joined CBS News to discuss.

Pills2Me is a Yale School of Public Health innovation success story. The company received its initial support and funding in 2020 from InnovateHealth Yale, YSPH’s social entrepreneurship program, and was recently named one of the U.S. recipients of the Google for Startups Black and Latino Founders Fund for 2023.

More than 2,400 children from Ukraine aged between six and 17 years old have been taken to 13 facilities across Belarus since Russia's full-scale invasion of Ukraine in early 2022, according to new research published by the Yale School of Public Health's Humanitarian Research Lab.

A new study reveals significant insights into the challenges that can occur for hepatitis C virus (HCV) micro-elimination efforts in people with HIV (PWH). Due to the opioid epidemic, the prevalence of co-infection with HIV and HCV has been increasing. If left untreated, HCV infection can lead to liver damage, cancer, and death. Although HIV requires lifelong therapy, HCV can be cured with a few months of oral medications.

The Yale School of Public Health is partnering with Nazarbayev University School of Medicine in Astana, Kazakhstan on an advanced research training program that will support promising scientists and clinicians interested in phylogeny of viruses and molecular epidemiology.

The Food and Drug Administration has approved the world’s first vaccine to prevent chikungunya, a mosquito-borne illness that can cause debilitating joint pain for months to years. YSPH Dr. Albert Ko comments.

Norovirus, the infamous wintertime stomach bug, is slowly on the rise in the United States. YSPH Dr. Albert Ko suggests one possible reason for the increase.